About MOTS-c Source

What This Site Is

MOTS-c Source keeps a calibration log of the peer-reviewed literature on MOTS-c: findings read straight off the studies, plotted against the temperature their data actually run, and written back in plain English. There is no clinic here and no clinical staff, no prescription written and no dose called; nothing on these pages is sold, supplied, or shipped. What you are reading is running commentary on published science, and only that.

The approach is borrowed from thermography — the practice of rendering invisible signals as a readable heat map. Established preclinical findings are logged where they run hot; the honest gaps — no human trials, no validated pharmacokinetics — are logged where they read cold. The aim is a calibrated read of what the studies actually measured, with the regulatory and research-use status read first.

What the Name Means

The word "Source" in the name is editorial framing. It marks the position this publisher occupies relative to the literature — a place that reads the science back to its sources and logs it straight — not a claim to be a vendor, a supplier, or a place that sells anything. MOTS-c is sold only as a research chemical for laboratory use, and this site sells nothing and recommends no supplier. The distinction is deliberate: the name describes an editorial stance toward the record, not a commercial service.

We take no position on whether anyone should use MOTS-c. We describe what published animal and cell studies have reported, cite each figure, and state the limits of the evidence plainly. Where a fact is uncertain or unestablished, we say so rather than fill the gap.

How We Handle the Evidence

Every quantitative claim on this site is tied to a numbered citation on the full reference list, drawn from PubMed-indexed studies and, for regulatory statements, from FDA sources. Animal and cell findings are labeled as such; human associations are kept separate from interventional outcomes. We do not convert rodent doses into human guidance, and we publish no dosing instructions or protocols. When the literature is thin or contested — single-lab findings, ancestry-dependent responses, the m.1382A>C diabetogenic variant — we flag it rather than smooth it over.